The ROSI Study (Risedronate in adults with osteogenesis imperfecta type 1): Improved BMD but high fracture rate persists

Barlow, S., Bradbury, L. A., Brown, M. A., Duncan, E. L., Geoghanen, F., Russell, R. G. G., Schofield, P. and Wass, J. A. H. (2006). The ROSI Study (Risedronate in adults with osteogenesis imperfecta type 1): Improved BMD but high fracture rate persists. In: Combined Meeting of the 3rd IOF Asia-Pacific Regional Conference on Osteoporosis and the 16th Annual Meeting of the ANZ Bone & Mineral Society, Port Douglas, Australia, (). 22 - 26 October 2006.

Author Barlow, S.
Bradbury, L. A.
Brown, M. A.
Duncan, E. L.
Geoghanen, F.
Russell, R. G. G.
Schofield, P.
Wass, J. A. H.
Title of paper The ROSI Study (Risedronate in adults with osteogenesis imperfecta type 1): Improved BMD but high fracture rate persists
Conference name Combined Meeting of the 3rd IOF Asia-Pacific Regional Conference on Osteoporosis and the 16th Annual Meeting of the ANZ Bone & Mineral Society
Conference location Port Douglas, Australia
Conference dates 22 - 26 October 2006
Place of Publication Port Douglas, Australia
Publisher ANZBMS
Publication Year 2006
Sub-type Oral presentation
Language eng
Subjects 11 Medical and Health Sciences
1112 Oncology and Carcinogenesis
1114 Paediatrics and Reproductive Medicine
Keyword Children
Fracture
Inherited disease
Osteogenesis imperfecta type 1
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown
Additional Notes Oral Abstracts, Item: 050

 
Versions
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Thu, 25 Feb 2010, 10:22:15 EST by Ms May Balasaize on behalf of Immunology and Cancer Research, Centre for